Variables | Number (n,%) | P value | |||
---|---|---|---|---|---|
TRM | CIR | DFS | OS | ||
Age of recipient | Â | 0.965 | 0.291 | 0.410 | 0.442 |
 <50 years | 31(64.6%) |  |  |  |  |
  ≥ 50 years | 17(35.4%) |  |  |  |  |
Underlying disease | Â | 0.675 | 0.115 | 0.151 | 0.157 |
 AML | 33(68.8%) |  |  |  |  |
 MDS-EB1/2 | 15(31.2%) |  |  |  |  |
ABO compatibility | Â | 0.264 | 0.009 | 0.38 | 0.484 |
 Compatible | 24(50.0%) |  |  |  |  |
 Incompatible | 24(50.0%) |  |  |  |  |
Donor type | Â | 0.271 | 0.653 | 0.544 | 0.560 |
 HLA-matched sibling | 12(25.0%) |  |  |  |  |
 Haploidentical | 36(75.0%) |  |  |  |  |
Prophylactic DLI | 2(4.2%) | 0.325 | 0.591 | 0.735 | 0.702 |
FLT3-ITD positive | 10(20.8%) | 0.067 | 0.868 | 0.068 | 0.041 |
Pre-transplantation FCM | Â | 0.056 | 0.504 | 0.291 | 0.232 |
 Negative | 23(47.9%) |  |  |  |  |
 Positive | 25(52.1%) |  |  |  |  |
Pre-transplantation WT1 | Â | 0.339 | 0.166 | 0.843 | 0.854 |
 WT1 < 0.6% | 19(40.4%) |  |  |  |  |
 WT1 ≥ 0.6% | 28(59.6%) |  |  |  |  |
Pre-transplantation MLL-PTD | Â | 0.105 | 0.967 | 0.202 | 0.202 |
 MLL-PTD/ABL ≥ 1.0% | 25(52.1%) |  |  |  |  |
 MLL-PTD/ABL<1.0% | 23(47.9%) |  |  |  |  |
Post-transplantation MLL-PTD |  | 0.277 | < 0.001 | < 0.001 | < 0.001 |
 MLL-PTD/ABL ≥ 1.0% | 8(16.7%) |  |  |  |  |
 MLL-PTD/ABL<1.0% | 38(79.2%) |  |  |  |  |